BACKGROUND: Children undergoing congenital heart surgery often receive corticosteroids with the aim of reducing the inflammatory response after cardiopulmonary bypass; however, the value of this approach is unclear. METHODS AND RESULTS: The Pediatric Health Information Systems Database was used to evaluate outcomes associated with corticosteroids in children (0 to 18 years of age) undergoing congenital heart surgery at 38 US centers from 2003 to 2008. Propensity scores were constructed to account for potential confounders: age, sex, race, prematurity, genetic syndrome, type of surgery (Risk Adjustment in Congenital Heart Surgery [RACHS-1] category), center, and center volume. Multivariable analysis, adjusting for propensity score and individual covariates, was performed to evaluate in-hospital mortality, postoperative length of stay, duration of ventilation, infection, and use of insulin. A total of 46 730 children were included; 54% received corticosteroids. In multivariable analysis, there was no difference in mortality among corticosteroid recipients and nonrecipients (odds ratio, 1.13; 95% confidence interval, 0.98 to 1.30). Corticosteroids were associated with longer length of stay (least square mean difference, 2.18 days; 95% confidence interval, 1.62 to 2.74 days), greater infection (odds ratio, 1.27; 95% confidence interval, 1.10 to 1.46), and greater use of insulin (odds ratio, 2.45; 95% confidence interval, 2.24 to 2.67). There was no difference in duration of ventilation. In analysis stratified by RACHS-1 category, no significant benefit was seen in any group, and the association of corticosteroids with increased morbidity was most prominent in RACHS-1 categories 1 through 3. CONCLUSION: In this observational analysis of children undergoing congenital heart surgery, we were unable to demonstrate a significant benefit associated with corticosteroids and found that corticosteroids may be associated with increased morbidity, particularly in lower-risk patients.
BACKGROUND:Children undergoing congenital heart surgery often receive corticosteroids with the aim of reducing the inflammatory response after cardiopulmonary bypass; however, the value of this approach is unclear. METHODS AND RESULTS: The Pediatric Health Information Systems Database was used to evaluate outcomes associated with corticosteroids in children (0 to 18 years of age) undergoing congenital heart surgery at 38 US centers from 2003 to 2008. Propensity scores were constructed to account for potential confounders: age, sex, race, prematurity, genetic syndrome, type of surgery (Risk Adjustment in Congenital Heart Surgery [RACHS-1] category), center, and center volume. Multivariable analysis, adjusting for propensity score and individual covariates, was performed to evaluate in-hospital mortality, postoperative length of stay, duration of ventilation, infection, and use of insulin. A total of 46 730 children were included; 54% received corticosteroids. In multivariable analysis, there was no difference in mortality among corticosteroid recipients and nonrecipients (odds ratio, 1.13; 95% confidence interval, 0.98 to 1.30). Corticosteroids were associated with longer length of stay (least square mean difference, 2.18 days; 95% confidence interval, 1.62 to 2.74 days), greater infection (odds ratio, 1.27; 95% confidence interval, 1.10 to 1.46), and greater use of insulin (odds ratio, 2.45; 95% confidence interval, 2.24 to 2.67). There was no difference in duration of ventilation. In analysis stratified by RACHS-1 category, no significant benefit was seen in any group, and the association of corticosteroids with increased morbidity was most prominent in RACHS-1 categories 1 through 3. CONCLUSION: In this observational analysis of children undergoing congenital heart surgery, we were unable to demonstrate a significant benefit associated with corticosteroids and found that corticosteroids may be associated with increased morbidity, particularly in lower-risk patients.
Authors: Kathy J Jenkins; Kimberlee Gauvreau; Jane W Newburger; Thomas L Spray; James H Moller; Lisa I Iezzoni Journal: J Thorac Cardiovasc Surg Date: 2002-01 Impact factor: 5.209
Authors: Gregory M Barker; Sean M O'Brien; Karl F Welke; Marshall L Jacobs; Jeffrey P Jacobs; Daniel K Benjamin; Eric D Peterson; James Jaggers; Jennifer S Li Journal: Ann Thorac Surg Date: 2010-03 Impact factor: 4.330
Authors: Eva Jensen; Svenerik Andréasson; Anders Bengtsson; Håkan Berggren; Rolf Ekroth; Lena Lindholm; John Ouchterlony Journal: Ann Thorac Surg Date: 2003-03 Impact factor: 4.330
Authors: Valerie A Schroeder; Jeffery M Pearl; Steven M Schwartz; Thomas P Shanley; Peter B Manning; David P Nelson Journal: Circulation Date: 2003-05-19 Impact factor: 29.690
Authors: Bernd Friedrich; Reinhold Schmidt; Irwin Reiss; Andreas Günther; Werner Seeger; Matthias Müller; Joseph Thul; Dietmar Schranz; Ludwig Gortner Journal: Crit Care Med Date: 2003-01 Impact factor: 7.598
Authors: Vijay Srinivasan; Philip C Spinella; Henry R Drott; Carey L Roth; Mark A Helfaer; Vinay Nadkarni Journal: Pediatr Crit Care Med Date: 2004-07 Impact factor: 3.624
Authors: Sara K Pasquali; Jennifer S Li; Xia He; Marshall L Jacobs; Sean M O'Brien; Matthew Hall; Robert D B Jaquiss; Karl F Welke; Eric D Peterson; Samir S Shah; J William Gaynor; Jeffrey P Jacobs Journal: Pediatrics Date: 2012-01-23 Impact factor: 7.124
Authors: H Hakan Poyrazoğlu; Zeynel Duman; Şerafettin Demir; M Kemal Avşar; Atakan Atalay; Bahattin Çiftçi; İhsan Bayraktar; Funda Tor Journal: Balkan Med J Date: 2016-03-01 Impact factor: 2.021
Authors: Eric M Graham; Andrew M Atz; Ryan J Butts; Nathaniel L Baker; Sinai C Zyblewski; Rachael L Deardorff; Stacia M DeSantis; Scott T Reeves; Scott M Bradley; Francis G Spinale Journal: J Thorac Cardiovasc Surg Date: 2011-05-20 Impact factor: 5.209
Authors: Michael L O'Byrne; Andrew C Glatz; Laura Mercer-Rosa; Matthew J Gillespie; Yoav Dori; Elizabeth Goldmuntz; Steven Kawut; Jonathan J Rome Journal: Am J Cardiol Date: 2014-10-16 Impact factor: 2.778
Authors: Eric M Graham; Reneé H Martin; Jason R Buckley; Sinai C Zyblewski; Minoo N Kavarana; Scott M Bradley; Bahaaldin Alsoufi; William T Mahle; Marc Hassid; Andrew M Atz Journal: J Am Coll Cardiol Date: 2019-08-06 Impact factor: 24.094
Authors: Eric M Graham; Andrew M Atz; Kimberly E McHugh; Ryan J Butts; Nathaniel L Baker; Robert E Stroud; Scott T Reeves; Scott M Bradley; Francis X McGowan; Francis G Spinale Journal: J Thorac Cardiovasc Surg Date: 2013-07-16 Impact factor: 5.209